Morning all!
Cello ( Cello Health (LON:CLL) ) – 124p – £130m – PER 14
Results For The 12 Months To End December 2018 – Revenue up 2.3%, PBT up 6.4%, EPS 13.7% and the Dividend is up 10%.
I keep saying this “Seems like an OK company but there’s not enough here to make me want to invest at present” – Don't see much reason to change that view.
LoopUp ( LoopUp (LON:LOOP) ) – 367p – £202m – PER 26
Results For The 12 Months To End December 2018 – Revenue up 96%, Adjusted Operating Profit up 521% (to £4.5m), Adjusted Diluted EPS up 111% to 9.3p. Net Debt is £10.6m.
I will be looking for updated Broker notes here today – Seems to be heading in the right direction.
Portmeirion ( Portmeirion (LON:PMP) ) – 1037p – £113m – PER 14
Results For The 12 Months To End December 2018 – Revenue up 5.7%, PBT up 10.1%, Basic EPS up 10.8% with the Dividend up 8.2%. Net Cash is up from £1.6m to £2.3m and Operating Margin is up from 10.7% to 11%. Current trading is in-line.
Looks like a steady ship – Will probably do a little more analysis here as looks like a reasonable growth with income opportunity.
Sopheon ( Sopheon (LON:SPE) ) – 1147p – £116m – PER 27
Results For The 12 Months To End December 2018 – Comfortably in-line with upgraded market expectations with Net Cash rising to $16.7m (from $9.5m) and the Dividend up from 2.5p to 3.25p. Order book ahead of last year.
Will probably never stop kicking myself for not paying up here sub 400p (not that long ago) but I still reckon it’s overvalued now at these levels.
Strix ( Strix (LON:KETL) ) – 167p – £317m – PER 11.2
Results For The 12 Months To End December 2018 – Revenue up 4.5% (CC), PBT up 3.2%, Net Debt at £27.5m (£45.9m last time), Basic EPS up 2.8% with the Final Dividend up 147% (FY 7p, up 141%).
Growth wise, I still…
